life scienc tool diagnost earn
ep top consensu ztss ep exceed estimate
better revenu weaker profit factor line ad
importantli releas initi ep guidanc slightli
consensu estim midpoint reflect like
conservat earli year modest oper leverag previous wide
advertis ramp commerci effort simparica trio diagnost offer
lap favor fx tailwind bp make chang
ep estim top end guidanc rais target price
ep greater convict growth prospect
coloss companion anim profit oper revenu
nice ahead estim us plan momentum
companion anim vs estimate driven apoquel cytopoint new
parasiticid proheart us livestock vs disappoint weak
beef dairi ex fx exceed view
impress strength companion vs estimate dermatolog parasiticid
dognost ou livestock slightli plan vs estimate asf
headwind gross margin improv meaning bp bp
plan admin expens increas bp bp plan contribut ebit
margin expans bp bp plan await cash flow/bal sheet data
share grind higher view share move higher better-than-expect
top-line target latest meaning companion anim growth particularli
inher profit categori importantli boast robust
pipelin compani histori maintain posit bia stock
upcom innov catalyst associ bundl capabl longer term visibl
growth amidst still robust fundament backdrop focu call
dynam dognost pipelin updat capit deploy prioriti risk includ
valuat metric
number share
 close
legal entiti disclosur statu non-u analyst us disclosur credit suiss seek busi
compani cover research report result investor awar firm may conflict interest could
affect object report investor consid report singl factor make invest decis
charl martineau univers toronto shift fundament demand slower traction new products/pipelin
profit tax
chang work capit
flow oper
free cash-flow firm
flow invest
chang net cash/debt
total liabil equiti
share wtd average
price book
roe stated-return
price
global leader develop anim health therapeut
livestock companion anim diversifi portfolio
product line directli market countri industri
blue sky scenario assum meaning profit
contribut oper effici initi greater expect
adopt futur recent launch product substanti share
gain well stronger anticip growth anim health
grey sky scenario assum lower expect ramp
profit weaker traction new product potenti distribut
manufactur disrupt fx macroeconom headwind
weak companion product anim fundament
 close
compani mention price
erin wilson wright certifi view express report accur reflect person view subject compani
secur part compens directli indirectli relat specif recommend view
express report
